Bedminster, NJ, United States of America

Mitchell Cayen

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 7.0

ph-index = 6

Forward Citations = 168(Granted Patents)


Company Filing History:


Years Active: 1998-2005

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: An Overview of Inventor Mitchell Cayen

Mitchell Cayen, based in Bedminster, New Jersey, is a prominent inventor recognized for his contributions to the field of pharmaceuticals. With a remarkable portfolio of 9 patents, Cayen has made significant strides in the treatment of airway diseases.

Latest Patents

Among his latest innovations, Cayen has developed patents related to the use of mometasone furoate, a corticosteroid, for treating upper airway diseases. The first patent discloses the administration of aerosolized particles of mometasone furoate in various forms such as dry powders, solutions, or aqueous suspensions. This method aims to address corticosteroid-responsive diseases affecting the surfaces of upper and lower airway passages and the lungs, specifically targeting conditions like allergic rhinitis and asthma. The second patent elaborates on similar applications of mometasone furoate, further establishing its therapeutic potential in managing airway passage and lung diseases.

Career Highlights

Mitchell Cayen is associated with Schering Corporation, a company renowned for its commitment to advancing healthcare through innovative pharmaceutical solutions. His work has contributed to the company's reputation for developing effective treatments for various medical conditions.

Collaborations

Throughout his career, Cayen has collaborated with esteemed professionals such as Joel A. Sequeira and Francis M. Cuss. These partnerships have played a crucial role in his research and the successful development of his patents, showcasing the importance of teamwork in scientific innovation.

Conclusion

In conclusion, Mitchell Cayen stands out as a dedicated inventor whose work in the pharmaceutical industry has produced groundbreaking treatments for airway diseases. His patents reflect a commitment to improving health outcomes for individuals suffering from conditions such as asthma and allergic rhinitis. With continued collaboration and innovation, Cayen’s contributions will undoubtedly leave a lasting impact on the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…